Compare AVXL & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | SUPV |
|---|---|---|
| Founded | 2004 | 1887 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.6M | 450.9M |
| IPO Year | N/A | 2016 |
| Metric | AVXL | SUPV |
|---|---|---|
| Price | $4.37 | $11.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $22.00 | $14.67 |
| AVG Volume (30 Days) | ★ 4.6M | 1.7M |
| Earning Date | 11-25-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $467,987,272.00 |
| Revenue This Year | N/A | $20.63 |
| Revenue Next Year | N/A | $22.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.86 | $4.54 |
| 52 Week High | $14.44 | $19.75 |
| Indicator | AVXL | SUPV |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 54.67 |
| Support Level | $3.62 | $10.75 |
| Resistance Level | $4.84 | $12.13 |
| Average True Range (ATR) | 0.42 | 0.80 |
| MACD | 0.23 | -0.08 |
| Stochastic Oscillator | 74.53 | 61.79 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.